What foods or plants naturally contain pinostrobin?

Pinostrobin is found in highest concentrations in fingerroot (Boesenbergia rotunda), a rhizomatous plant used in Southeast Asian cuisine and traditional medicine. It is also present in certain propolis samples derived from tropical bee species and in small amounts in other members of the Zingiberaceae (ginger) family.

How does pinostrobin induce quinone reductase and why does that matter?

Pinostrobin activates the Nrf2/ARE signaling pathway, which transcriptionally upregulates quinone reductase (NQO1), a phase II enzyme that detoxifies reactive quinone intermediates and reduces oxidative damage. In murine hepatoma cell studies, it achieved induction potency of approximately 110,000 units per gram, suggesting strong chemopreventive potential at the cellular level. This mechanism is relevant to cancer chemoprevention research, though it has not been validated in human trials.

Can pinostrobin help with stomach ulcers?

Animal studies using rat ulcer models have demonstrated that pinostrobin exhibits gastroprotective effects, reducing ulcer lesion scores compared to controls. Its mechanism appears to be indirect antioxidant activity that protects the gastric mucosal lining from oxidative stress rather than direct inhibition of stomach acid secretion like proton pump inhibitors. No human clinical data currently support the use of pinostrobin as an anti-ulcer treatment.

Does pinostrobin have antimicrobial activity against specific bacteria?

Preclinical studies have documented antimicrobial activity for pinostrobin, with reported effects against gram-positive bacteria and some fungal organisms, consistent with the broader antimicrobial profile of flavanones. Its mechanism is thought to involve disruption of microbial cell membranes and inhibition of bacterial enzyme systems, though specific minimum inhibitory concentration (MIC) values vary across studies and strains. This activity has not been validated in human infectious disease clinical trials.

Is pinostrobin safe to take as a supplement?

No established safe dosage range for isolated pinostrobin exists in humans, as clinical pharmacokinetic and toxicology studies have not been published. While fingerroot (its primary dietary source) has a long history of culinary use in Southeast Asia without notable adverse events, concentrated supplement extracts may behave differently. Until human safety data are available, supplementation with isolated pinostrobin should be approached cautiously, particularly by pregnant individuals, those on pharmaceutical medications, or those with liver conditions.

What does the research quality show about pinostrobin's effectiveness in humans?

Most evidence for pinostrobin comes from preclinical studies in cell cultures and animal models, with limited human clinical trials currently available. While enzyme induction and anti-ulcer effects have been demonstrated in laboratory settings, these results have not yet been conclusively replicated in controlled human studies. This means pinostrobin's real-world efficacy in people remains uncertain and requires further research before strong claims can be made.

Are there any known drug interactions with pinostrobin?

Because pinostrobin is a potent inducer of quinone reductase and potentially other metabolic enzymes, it may theoretically affect how the body processes certain medications, though specific interaction studies are limited. If you take prescription medications—particularly those metabolized by Phase I or Phase II liver enzymes—consult a healthcare provider before adding pinostrobin supplements. The enzyme-inducing properties that make pinostrobin potentially beneficial could alter drug bioavailability or effectiveness.

Who would benefit most from pinostrobin supplementation?

Pinostrobin may be of interest to individuals seeking enhanced antioxidant enzyme support or those with recurrent digestive issues, based on animal model evidence, though human studies are lacking. People with compromised detoxification capacity or those exposed to oxidative stress might theoretically benefit from its quinone reductase-inducing properties. However, without robust human clinical data, it is difficult to definitively identify who would experience the most benefit from supplementation.

Pinostrobin

Pinostrobin is a naturally occurring flavanone found in fingerroot (Boesenbergia rotunda) and certain propolis varieties that exerts its primary effects through induction of phase II detoxification enzymes and indirect antioxidant mechanisms. Preclinical research highlights its notable quinone reductase-inducing activity and gastroprotective properties, though human clinical data remain limited.

Category: Compound Evidence: 4/10 Tier: Emerging

Origin & History

Pinostrobin is a natural flavanone compound primarily extracted from the rhizomes of Boesenbergia rotunda (fingerroot or Thai ginger), a plant native to Southeast Asia, where it occurs at concentrations of 2-3%. It is isolated through petroleum ether partitioning of rhizome powder followed by recrystallization with cold methanol.

Historical & Cultural Context

Boesenbergia rotunda, known as 'Temu kunci' in Malaysia and Indonesia, has been used in traditional Southeast Asian herbal medicine. Pinostrobin now serves as a quality control marker for B. rotunda rhizome products, though specific historical indications for the compound itself are not documented.

Health Benefits

• Potent enzyme induction: Induces quinone reductase in murine hepatoma cells at ~110,000 units/g (preclinical evidence only)
• Anti-ulcer activity: Demonstrated protective effects against ulcers in rat models through indirect antioxidant action (animal studies)
• Antimicrobial properties: Shows activity against various pathogens including Helicobacter pylori (in vitro evidence)
• Anti-cancer potential: Exhibits anti-leukemic activity in laboratory studies (preclinical data)
• Neuroprotective effects: Demonstrated protective effects on neural cells (in vitro studies only)

How It Works

Pinostrobin induces quinone reductase, a key phase II detoxification enzyme, likely through activation of the Nrf2/ARE (antioxidant response element) signaling pathway, which upregulates cytoprotective gene expression in hepatic cells. Its anti-ulcer activity is mediated indirectly via antioxidant pathways that reduce oxidative stress on gastric mucosa rather than direct acid suppression. Additionally, pinostrobin's antimicrobial action is thought to involve disruption of bacterial cell membrane integrity and inhibition of microbial enzyme systems, though the precise molecular targets have not been fully characterized.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses have been conducted on pinostrobin. All available research is limited to preclinical in vitro and in vivo animal studies, with no PubMed PMIDs for human studies identified.

Clinical Summary

The current evidence base for pinostrobin is limited predominantly to in vitro and animal studies, with no robust randomized controlled trials in humans published to date. In murine hepatoma cell assays, pinostrobin demonstrated quinone reductase induction at approximately 110,000 units per gram, placing it among potent phase II enzyme inducers in preclinical models. Rat model studies have shown statistically significant gastroprotective effects against experimentally induced ulcers, attributed to its indirect antioxidant capacity rather than direct acid neutralization. Given the absence of human pharmacokinetic data and clinical trials, all purported benefits must be interpreted with caution and cannot yet be extrapolated to therapeutic use in humans.

Nutritional Profile

Pinostrobin (5-hydroxy-7-methoxyflavanone, C₁₆H₁₄O₄, MW 270.28) is a methylated flavanone, not a macronutrient source. It is found naturally in honey (particularly from Apis mellifera, ~1-5 mg/kg), galangal rhizome (Alpinia galanga, ~0.5-2% dry weight), Boesenbergia rotunda (fingerroot), and various Pinus species. As a single bioactive compound, it contains no appreciable vitamins, minerals, fiber, or protein. Key bioactive features include the 7-methoxy group (enhancing lipophilicity and membrane permeability relative to unsubstituted flavanones) and the 5-hydroxy group (critical for antioxidant enzyme induction). Bioavailability is moderate for a flavonoid due to its methylation increasing lipophilicity (LogP ~2.6), but it undergoes extensive Phase I/II hepatic metabolism (CYP-mediated demethylation and glucuronidation), resulting in limited systemic bioavailability estimated at ~10-20% in rodent models. Encapsulation in lipid-based delivery systems or co-administration with piperine may improve oral absorption.

Preparation & Dosage

No clinically studied dosage ranges exist as human trials have not been conducted. Preclinical cultures have yielded up to 3.43 µg/g pinostrobin content, but no human dosing data or standardization protocols are available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Pinostrobin pairs well with **piperine** (5-20 mg, from black pepper), which inhibits CYP3A4 and UDP-glucuronosyltransferases, significantly boosting pinostrobin's oral bioavailability by reducing first-pass metabolism. **Galangal extract** (standardized to contain pinocembrin and galangin) provides complementary flavonoids that share overlapping NF-κB and Nrf2 pathway modulation, amplifying both anti-inflammatory and phase II enzyme induction effects beyond what pinostrobin achieves alone. **Curcumin** (200-500 mg) synergizes through convergent suppression of COX-2 and iNOS pathways while both compounds independently activate Nrf2-mediated antioxidant response elements, and **quercetin** (100-250 mg) complements pinostrobin's antimicrobial action against H. pylori through distinct membrane disruption mechanisms and enhances anti-cancer potential via combined inhibition of PI3K/Akt and MAPK signaling cascades.

Safety & Interactions

No formal human safety trials for isolated pinostrobin have been published, making it impossible to establish a confirmed safe dosage range or comprehensive adverse effect profile at this time. Because pinostrobin induces phase II detoxification enzymes via Nrf2 pathways, it theoretically could alter the metabolism of co-administered drugs processed through these pathways, warranting caution when combined with medications with narrow therapeutic windows. Pregnant and breastfeeding individuals should avoid isolated pinostrobin supplementation due to a complete lack of safety data in these populations. Individuals with known flavonoid allergies or those taking anticoagulants, hepatotoxic drugs, or CYP450-sensitive medications should consult a healthcare provider before use.